Pulmonary non-tuberculous mycobacterial infections

被引:1
作者
Daley, C. L. [1 ,2 ]
Griffith, D. E. [3 ]
机构
[1] Natl Jewish Hlth, Div Mycobacterial & Resp Infect, Denver, CO 80206 USA
[2] Univ Colorado, Denver, CO 80202 USA
[3] Univ Texas Hlth Ctr Tyler, Tyler, TX USA
关键词
CLINICAL-RELEVANCE; MACROLIDE RESISTANCE; CLARITHROMYCIN; DISEASE; MALMOENSE; DIAGNOSIS; FORTUITUM; FEATURES;
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:665 / 671
页数:7
相关论文
共 35 条
[1]   Mycobacterium xenopi pulmonary infections: a multicentric retrospective study of 136 cases in north-east France [J].
Andrejak, C. ;
Lescure, F-X ;
Pukenyte, E. ;
Douadi, Y. ;
Yazdanpanah, Y. ;
Laurans, G. ;
Schmit, J-L ;
Jounieaux, V. .
THORAX, 2009, 64 (04) :291-296
[2]   Nontuberculous Pulmonary Mycobacteriosis in Denmark Incidence and Prognostic Factors [J].
Andrejak, Claire ;
Thomsen, Vibeke O. ;
Johansen, Isik S. ;
Riis, Anders ;
Benfield, Thomas L. ;
Duhaut, Pierre ;
Sorensen, Henrik T. ;
Lescure, Francois-Xavier ;
Thomsen, Reimar W. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181 (05) :514-521
[3]   Nontuberculous Mycobacteria-associated Lung Disease in Hospitalized Persons, United States, 1998-2005 [J].
Billinger, Megan E. ;
Olivier, Kenneth N. ;
Viboud, Cecile ;
de Oca, Ruben Montes ;
Steiner, Claudia ;
Holland, Steven M. ;
Prevots, D. Rebecca .
EMERGING INFECTIOUS DISEASES, 2009, 15 (10) :1562-1569
[4]   ACTIVITIES OF 4 MACROLIDES, INCLUDING CLARITHROMYCIN, AGAINST MYCOBACTERIUM-FORTUITUM, MYCOBACTERIUM-CHELONAE, AND M-CHELONAE-LIKE ORGANISMS [J].
BROWN, BA ;
WALLACE, RJ ;
ONYI, GO ;
DEROSAS, V ;
WALLACE, RJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (01) :180-184
[5]  
Butler W, 1999, NONTUBERCULOUS MYCOB
[6]   Nontuberculous Mycobacterial Disease Prevalence and Risk Factors: A Changing Epidemiology [J].
Cassidy, P. Maureen ;
Hedberg, Katrina ;
Saulson, Ashlen ;
McNelly, Erin ;
Winthrop, Kevin L. .
CLINICAL INFECTIOUS DISEASES, 2009, 49 (12) :E124-E129
[7]   Respiratory infections associated with nontuberculous mycobacteria in non-HIV patients [J].
Dailloux, M. ;
Abalain, M. L. ;
Laurain, C. ;
Lebrun, L. ;
Loos-Ayav, C. ;
Lozniewski, A. ;
Maugein, J. .
EUROPEAN RESPIRATORY JOURNAL, 2006, 28 (06) :1211-1215
[8]   An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases [J].
Griffith, David E. ;
Aksamit, Timothy ;
Brown-Elliott, Barbara A. ;
Catanzaro, Antonino ;
Daley, Charles ;
Gordin, Fred ;
Holland, Steven M. ;
Horsburgh, Robert ;
Huitt, Gwen ;
Iademarco, Michael F. ;
Iseman, Michael ;
Olivier, Kenneth ;
Ruoss, Stephen ;
von Reyn, C. Fordham ;
Wallace, Richard J., Jr. ;
Winthrop, Kevin .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 175 (04) :367-416
[9]   Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease [J].
Griffith, David E. ;
Brown-Elliott, Barbara A. ;
Langsjoen, Brett ;
Zhang, Yansheng ;
Pan, Xi ;
Girard, William ;
Nelson, Kenwyn ;
Caccitolo, James ;
Alvarez, Julio ;
Shepherd, Sara ;
Wilson, Rebecca ;
Graviss, Edward A. ;
Wallace, Richard J., Jr. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 174 (08) :928-934
[10]   Thrice-weekly clarithromycin-containing regimen for treatment of Mycobacterium kansasii lung disease:: Results of a preliminary study [J].
Griffith, DE ;
Brown-Elliott, BA ;
Wallace, RJ .
CLINICAL INFECTIOUS DISEASES, 2003, 37 (09) :1178-1182